XOMA Corporation (XOMAP)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

XOMA Corporation (XOMAP) is down 1.1% since the beginning of the year. At $26 per share, XOMAP is trading 15.0% below its 52-week high of $30. Investors who bought $1,000 worth of XOMAP shares 5 years ago would now be looking at an investment worth $1,526.

XOMA Corporation (XOMAP) has returned -1.13% so far this year and 7.47% over the past 12 months.

Based on dividend-adjusted daily data since Dec 16, 2020, XOMAP's average daily return is +0.04%, while the average monthly return is +0.77%. At this rate, an investment would double in approximately 7.5 years.

Historically, 75% of months were positive and 25% were negative. The best month was Dec 2023 with a return of +10.5%, while the worst month was Oct 2023 at -6.6%. The longest winning streak lasted 13 consecutive months, and the longest losing streak was 3 months.

On a daily basis, XOMAP closed higher 45% of trading days. The best single day was Dec 18, 2023 with a return of +10.6%, while the worst single day was Oct 27, 2023 at -5.7%.

XOMA Corporation has an annualized alpha of 9.40%, beta of 0.08, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since December 17, 2020.

• This stock captured 25.87% of S&P 500 Index gains and tended to rise during its downturns (downside capture of -1.53%) - a profile typical of hedging or uncorrelated assets.
• Beta of 0.08 may look defensive, but with R2 of 0.01 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

XOMAP ranks 59 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

The table below present risk-adjusted performance metrics for XOMA Corporation (XOMAP) and compare them to S&P 500 Index.

XOMA Corporation provided a 8.45% dividend yield over the last twelve months, with an annual payout of $2.16 per share. The company has been increasing its dividends for 4 consecutive years.

The table displays the monthly dividend distributions for XOMA Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the XOMA Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the XOMA Corporation was 14.28%, occurring on Oct 25, 2022. Recovery took 175 trading sessions.

The current XOMA Corporation drawdown is 6.39%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of XOMA Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how XOMA Corporation is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.